Cargando…

1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV

BACKGROUND: HIV and HCV are both treatable viruses for which routine screening among specific age cohorts is recommended. New York State requires patient consent prior to screening for HIV but not HCV. To estimate the impact of the consent requirement, we compared rates of HIV and HCV screening. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Tlamsa, Aileen, Heo, Moonseong, Thompson, Devin, Moir, Lorlette, Shukla, Shuchin, Weiss, Jeffrey, Litwin, Alain, Felsen, Uriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253050/
http://dx.doi.org/10.1093/ofid/ofy210.1111
_version_ 1783373407249760256
author Tlamsa, Aileen
Heo, Moonseong
Thompson, Devin
Moir, Lorlette
Shukla, Shuchin
Weiss, Jeffrey
Litwin, Alain
Felsen, Uriel
author_facet Tlamsa, Aileen
Heo, Moonseong
Thompson, Devin
Moir, Lorlette
Shukla, Shuchin
Weiss, Jeffrey
Litwin, Alain
Felsen, Uriel
author_sort Tlamsa, Aileen
collection PubMed
description BACKGROUND: HIV and HCV are both treatable viruses for which routine screening among specific age cohorts is recommended. New York State requires patient consent prior to screening for HIV but not HCV. To estimate the impact of the consent requirement, we compared rates of HIV and HCV screening. METHODS: We performed a retrospective study of all adult patients admitted to a tertiary-care hospital in the Bronx, NY, between April 2015 and June 2016. During the study period, automated prompts in the electronic medical record facilitated screening for HIV among patients ages 21–64, and for HCV among patients born between1945-1965. We compared the proportions of patients qualifying for screening for HIV, HCV, or both who were appropriately screened prior to discharge to calculate an adjusted risk difference between performance of HIV and HCV screening. Using the local prevalence of undiagnosed HIV, we estimated the number of missed HIV diagnoses attributable to the difference in screening rates. RESULTS: A total of 21,413 unique hospitalized patients ages 21–64 and/or born between 1945–1965 were analyzed. Among those qualifying for screening for HIV alone or HCV alone, 39.7% and 58.6% were screened prior to discharge, respectively. Among those qualifying for both HIV and HCV screening, 6.7% were screened for HIV alone, 29.3% were screened for HCV alone, and 30.3% were screened for both. The risk difference between HCV and HIV screening adjusted for patient and admission characteristics was 22.0% (95% CI 20.6%-23.4%). Using an estimated prevalence of undiagnosed HIV of 0.2%, this risk difference corresponds to approximately four (95% CI 3.6–4.1) missed cases of HIV during the study period. CONCLUSION: There was a large difference in the number of patients appropriately screened for HIV compared with HCV. While the requirement for consent was the only operational difference in performing routine screening for HIV compared with HCV, differences in how the two viruses are perceived may also have contributed to the observed difference in screening rates. Nevertheless, our findings suggest that removing the requirement for consent prior to HIV screening may increase the number of cases of previously undiagnosed HIV identified by routine screening. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6253050
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62530502018-11-28 1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV Tlamsa, Aileen Heo, Moonseong Thompson, Devin Moir, Lorlette Shukla, Shuchin Weiss, Jeffrey Litwin, Alain Felsen, Uriel Open Forum Infect Dis Abstracts BACKGROUND: HIV and HCV are both treatable viruses for which routine screening among specific age cohorts is recommended. New York State requires patient consent prior to screening for HIV but not HCV. To estimate the impact of the consent requirement, we compared rates of HIV and HCV screening. METHODS: We performed a retrospective study of all adult patients admitted to a tertiary-care hospital in the Bronx, NY, between April 2015 and June 2016. During the study period, automated prompts in the electronic medical record facilitated screening for HIV among patients ages 21–64, and for HCV among patients born between1945-1965. We compared the proportions of patients qualifying for screening for HIV, HCV, or both who were appropriately screened prior to discharge to calculate an adjusted risk difference between performance of HIV and HCV screening. Using the local prevalence of undiagnosed HIV, we estimated the number of missed HIV diagnoses attributable to the difference in screening rates. RESULTS: A total of 21,413 unique hospitalized patients ages 21–64 and/or born between 1945–1965 were analyzed. Among those qualifying for screening for HIV alone or HCV alone, 39.7% and 58.6% were screened prior to discharge, respectively. Among those qualifying for both HIV and HCV screening, 6.7% were screened for HIV alone, 29.3% were screened for HCV alone, and 30.3% were screened for both. The risk difference between HCV and HIV screening adjusted for patient and admission characteristics was 22.0% (95% CI 20.6%-23.4%). Using an estimated prevalence of undiagnosed HIV of 0.2%, this risk difference corresponds to approximately four (95% CI 3.6–4.1) missed cases of HIV during the study period. CONCLUSION: There was a large difference in the number of patients appropriately screened for HIV compared with HCV. While the requirement for consent was the only operational difference in performing routine screening for HIV compared with HCV, differences in how the two viruses are perceived may also have contributed to the observed difference in screening rates. Nevertheless, our findings suggest that removing the requirement for consent prior to HIV screening may increase the number of cases of previously undiagnosed HIV identified by routine screening. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6253050/ http://dx.doi.org/10.1093/ofid/ofy210.1111 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Tlamsa, Aileen
Heo, Moonseong
Thompson, Devin
Moir, Lorlette
Shukla, Shuchin
Weiss, Jeffrey
Litwin, Alain
Felsen, Uriel
1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV
title 1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV
title_full 1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV
title_fullStr 1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV
title_full_unstemmed 1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV
title_short 1278. Comparing Rates of Routine HIV and HCV Screening to Estimate the Impact of Consent on Identifying Patients With Undiagnosed HIV
title_sort 1278. comparing rates of routine hiv and hcv screening to estimate the impact of consent on identifying patients with undiagnosed hiv
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253050/
http://dx.doi.org/10.1093/ofid/ofy210.1111
work_keys_str_mv AT tlamsaaileen 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv
AT heomoonseong 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv
AT thompsondevin 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv
AT moirlorlette 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv
AT shuklashuchin 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv
AT weissjeffrey 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv
AT litwinalain 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv
AT felsenuriel 1278comparingratesofroutinehivandhcvscreeningtoestimatetheimpactofconsentonidentifyingpatientswithundiagnosedhiv